Caribou Biosciences's total assets for Q4 2024 were $313.31M, a decrease of -9.01% from the previous quarter. CRBU total liabilities were $60.36M for the fiscal quarter, a -4.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.